Target intelligence / Profile preview

Keratin and stratum corneum protein matrix (SC matrix)

Target
SC matrix
Molecular classification
Structural protein, Other
01

Overview

The keratin and stratum corneum protein matrix constitutes the primary physical barrier of the human skin, located in the outermost layer of the epidermis. This matrix is composed of keratin intermediate filaments bundled by filaggrin within corneocytes, which are further encased in a cornified envelope and embedded in a lipid-rich extracellular matrix (StatPearls, Physiology, Stratum Corneum, 2023). Its primary biological function is to prevent transepidermal water loss and protect the body from environmental insults, including pathogens, chemicals, and UV radiation. In various dermatological diseases such as psoriasis, ichthyosis, and actinic keratosis, the matrix undergoes pathological thickening or abnormal differentiation, known as hyperkeratosis (PubMed, Keratolytic agents in dermatology, 2021). Therapeutic intervention often involves the use of keratolytic agents like salicylic acid or urea, which work by breaking down the protein bonds or increasing the hydration of the keratin matrix to facilitate the shedding of dead skin cells (PubChem, Salicylic Acid, 2024). Additionally, the high affinity of certain antifungal drugs for keratin allows for effective treatment of dermatophyte infections localized within this matrix.

Other names
Stratum corneumCornified envelopeKeratin matrixEpidermal barrierHorny layer
02

Mechanism of action

Keratolytic agents work by increasing the hydration of the stratum corneum or by dissolving the intercellular 'cement' (desmosomes) that holds corneocytes together, leading to the softening and shedding of the keratin layer. Some drugs, like terbinafine, exhibit high keratin affinity, allowing them to persist in the matrix to treat fungal infections.

03

Biological functions

Barrier functionProtectionHydrationStructural integrityDesquamation
04

Disease associations

PsoriasisIchthyosisHyperkeratosisDermatitisInfectionActinic keratosis
05

Safety considerations

Skin irritationSystemic toxicity (e.g., salicylism from extensive topical use)Impaired barrier functionIncreased sensitivity to UV radiationSecondary skin infections
06

Interacting drugs

Salicylic acid

7 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Stratum corneum thicknessKeratin 1 (KRT1) expressionKeratin 10 (KRT10) expressionFilaggrin levels

Beyond the preview

Go deeper on Keratin and stratum corneum protein matrix (SC matrix).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin and stratum corneum protein matrix (SC matrix).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call